Literature DB >> 2424279

Post-operative thromboembolism in neurosurgery. A study on the prophylactic effect of calf muscle stimulation plus dextran compared to low-dose heparin.

S Boström, E Holmgren, O Jonsson, S Lindberg, B Lindström, I Winsö, B Zachrisson.   

Abstract

This study compares the safety and effectiveness of two methods for the prophylaxis of post-operative thromboembolism in neurosurgical patients: A: low-dose heparin (5,000 IU X 2 s.c.) started preoperatively and continued daily for one week post-operatively, and B: per-operative electrical calf muscle stimulation with groups of impulses plus post-operative dextran infusions every other day for one week. Neurosurgical patients aged 40 years or more with normal laboratory coagulation values and operated under general anaesthesia were included. The 125:I-fibrinogen uptake test (FUT) was used for screening and phlebography for verification of deep venous thrombosis (DVT). 122 patients entered the study and 104 completed the prophylactic protocol, 58 in group A and 46 in group B. The two groups were comparable according to pre-operative data and distribution of diagnoses. 89 patients completed screening for post-operative DVT. We found an overall incidence of 5/49 (10 percent) DVT in group A and 5/40 (13 percent) in group B, compared to a frequency of 32-50 percent for controls without prophylaxis reported in the literature, In spite of prophylaxis our patients with intracranial neoplasms and intracranial vascular disease showed a relatively higher incidence of DVT, 4/23 (17 percent) and 4/14 (29 percent) respectively, compared to patients with spinal diagnoses 2/25 (8 percent). In combination with cranial diagnoses paretic lower limbs meant an apparent risk factor, 4/7 (57 percent). However, paretic limbs appearing in cases with spinal disorders did not predetermine an unsuccessful prophylaxis, 2/14 (14 percent). Blood loss, transfusion requirements and post-operative complications did not differ significantly between the two prophylactic groups.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2424279     DOI: 10.1007/bf01812279

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  16 in total

1.  Pulmonary embolism as a cause of death in the neurosurgical patient.

Authors:  N WETZEL; M C ANDERSON; T W SHIELDS
Journal:  J Neurosurg       Date:  1960-07       Impact factor: 5.115

2.  Safety of mini-dose heparin administration for neurosurgical patients.

Authors:  H G Barnett; J R Clifford; R C Llewellyn
Journal:  J Neurosurg       Date:  1977-07       Impact factor: 5.115

3.  Failure of low-dose heparin to prevent significant thromboembolic complications in high-risk surgical patients: interim report of prospective trial. Groote Schuur Hospital Thromboembolus Study Group.

Authors: 
Journal:  Br Med J       Date:  1979-06-02

4.  Thromboembolism and brain tumors.

Authors:  R Brisman; J Mendell
Journal:  J Neurosurg       Date:  1973-03       Impact factor: 5.115

5.  The incidence of postoperative venous thrombosis of the legs. A comparative study on the prophylactic effect of dextran 70 and electrical calf-muscle stimulation.

Authors:  J Becker; B Schampi
Journal:  Acta Chir Scand       Date:  1973

6.  Incidence of lower extremity deep vein thrombosis in neurosurgical patients.

Authors:  J B Valladares; J Hankinson
Journal:  Neurosurgery       Date:  1980-02       Impact factor: 4.654

7.  Deep vein thrombosis after aneurysm surgery.

Authors:  A Tapaninaho
Journal:  Acta Neurochir (Wien)       Date:  1985       Impact factor: 2.216

8.  Electrically induced short-lasting tetanus of the calf muscles for prevention of deep vein thrombosis.

Authors:  B Lindström; K Korsan-Bengtsen; O Jonsson; B Petruson; S Pettersson; J Wikstrand
Journal:  Br J Surg       Date:  1982-04       Impact factor: 6.939

9.  Prophylaxis of thromboembolism in the neurosurgical patient: a review.

Authors:  S K Powers; M S Edwards
Journal:  Neurosurgery       Date:  1982-04       Impact factor: 4.654

10.  Influence of factor VIII/von Willebrand factor protein (F VIII/vWF) and F VIII/vWF-poor cryoprecipitate on post-ischemic microvascular reperfusion in the central nervous system.

Authors:  J M Hallenbeck; T W Furlow; H R Gralnick
Journal:  Stroke       Date:  1981 Jan-Feb       Impact factor: 7.914

View more
  15 in total

1.  Fibrinopeptide A and fibrinogen fragment B beta 15-42 and their relation to the operative trauma and post-operative thromboembolism in neurosurgical patients.

Authors:  S Boström; E Holmgren; O Jonsson; B Lindström; L Stigendal
Journal:  Acta Neurochir (Wien)       Date:  1987       Impact factor: 2.216

2.  Risk factors for venous thromboembolism in patients undergoing craniotomy for neoplastic disease.

Authors:  Kristopher T Kimmell; Kevin A Walter
Journal:  J Neurooncol       Date:  2014-08-23       Impact factor: 4.130

Review 3.  Venous thromboembolism prophylaxis in brain tumor patients undergoing craniotomy: a meta-analysis.

Authors:  Nasser Alshehri; David J Cote; M Maher Hulou; Ahmad Alghamdi; Ali Alshahrani; Rania A Mekary; Timothy R Smith
Journal:  J Neurooncol       Date:  2016-09-03       Impact factor: 4.130

Review 4.  Postoperative intracranial haemorrhage: a review.

Authors:  Marc A Seifman; Phillip M Lewis; Jeffrey V Rosenfeld; Peter Y K Hwang
Journal:  Neurosurg Rev       Date:  2011-01-19       Impact factor: 3.042

5.  Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology.

Authors:  C K Goldman; J Kim; W L Wong; V King; T Brock; G Y Gillespie
Journal:  Mol Biol Cell       Date:  1993-01       Impact factor: 4.138

6.  Does peroperative external pneumatic leg muscle compression prevent post-operative venous thrombosis in neurosurgery?

Authors:  O Bynke; J Hillman; C Lassvik
Journal:  Acta Neurochir (Wien)       Date:  1987       Impact factor: 2.216

7.  Thromboembolic phenomena in neurosurgical patients operated upon for primary and metastatic brain tumors.

Authors:  S Constantini; R Kornowski; S Pomeranz; Z H Rappaport
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

8.  Adjuvant enoxaparin therapy may decrease the incidence of postoperative thrombotic events though does not increase the incidence of postoperative intracranial hemorrhage in patients with meningiomas.

Authors:  Tene A Cage; Kathleen R Lamborn; Marcus L Ware; Anna Frankfurt; Lenna Chakalian; Mitchell S Berger; Michael W McDermott
Journal:  J Neurooncol       Date:  2009-05-09       Impact factor: 4.130

Review 9.  Prophylaxis of Venous Thrombosis in Neurocritical Care Patients: An Evidence-Based Guideline: A Statement for Healthcare Professionals from the Neurocritical Care Society.

Authors:  Paul Nyquist; Cynthia Bautista; Draga Jichici; Joseph Burns; Sanjeev Chhangani; Michele DeFilippis; Fernando D Goldenberg; Keri Kim; Xi Liu-DeRyke; William Mack; Kim Meyer
Journal:  Neurocrit Care       Date:  2016-02       Impact factor: 3.210

Review 10.  Prevention of venous thromboembolism in spinal surgery.

Authors:  S Brambilla; C Ruosi; G A La Maida; S Caserta
Journal:  Eur Spine J       Date:  2003-11-11       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.